ABSTRACT
PURPOSE: To describe a case report of a 34 years-old patient with Crohn's Disease and two episodes of Ocular Myositis. METHODS: The research methodology employed in this study consisted of a retrospective review of the patient's complete medical history. RESULTS: Crohn's Disease is a chronic inflammatory bowel disorder known to be associated with a wide range of extraintestinal manifestations. Ocular abnormalities, such as episcleritis and uveitis, are commonly observed. However, orbital myositis is an extremely rare ocular extraintestinal manifestations characterized by acute ocular pain that worsens with eye movements and is often accompanied by diplopia. In this case report, we present the case of a 34-year-old woman with a confirmed diagnosis of Crohn's Disease, who experienced two episodes of acute orbital pain exacerbated by ocular movements and diplopia. The diagnosis was established through clinical evaluation and radiologic imaging, with confirmation after a good response to systemic corticosteroids. She responded favorably to systemic corticosteroid therapy on both episodes, and no additional treatment was required. As of now, she remains stable without any ocular sequelae. CONCLUSION: It is important to note that orbital myositis is an uncommon ocular manifestation associated with Crohn's Disease, and prompt recognition and management are crucial to achieve successful outcomes.
Subject(s)
Crohn Disease , Myositis , Orbital Myositis , Female , Humans , Adult , Crohn Disease/complications , Crohn Disease/diagnosis , Crohn Disease/drug therapy , Orbital Myositis/complications , Orbital Myositis/diagnosis , Diplopia/diagnosis , Diplopia/etiology , Pain/complicationsABSTRACT
Este estudio, una serie de 2casos y revisión de la literatura, pretende describir el segundo y tercer caso conocido de hemorragia supracoroidea diferida (DSCH) tras una queratoplastia endotelial automatizada con pelado de Descemet (DSAEK). La hemorragia supracoroidea consiste en la presencia de sangre en el espacio supracoroideo. La agudeza visual final no suele superar el 0,1 (escala decimal). Ambos casos presentan factores de riesgo: alta miopía, cirugía intraocular previa, hipertensión arterial o estar anticoagulados. El diagnóstico de hemorragia supracoroidea diferida se realizó en la primera visita de seguimiento: referían dolor intenso y agudo horas después de la cirugía. Fueron tratados con drenaje transescleral. La hemorragia supracoroidea diferida es una complicación rara pero devastadora y puede ocurrir después de un trasplante lamelar, como la queratoplastia endotelial automatizada con pelado de Descemet. Conocer esta complicación así como sus factores de riesgo permitirá un diagnóstico precoz, lo que mejorará el pronóstico de los pacientes (AU)
This study, a case series of 2patients and a literature review, aims to describe the second and third known cases of delayed suprachoroidal hemorrhage after Descemet stripping automated endothelial keratoplasty (DSAEK). The suprachoroidal hemorrhage is defined as the presence of blood in the suprachoroidal space; final visual acuity is rarely greater than 0.1 (decimal scale). Both cases presented had known risk factors: high myopia, previous ocular surgeries, arterial hypertension, and being under anticoagulant therapy. The diagnosis of delayed suprachoroidal hemorrhage was made at the 24-hour follow-up visit, as they recalled a sudden and tremendous acute pain hours after surgery. Both cases were drained through a scleral approach. Delayed suprachoroidal hemorrhage is a rare but devastating consequence that can occur after DSAEK. Awareness of the most critical risk factors allows for early identification, which is of paramount importance for the prognosis of these patients (AU)
Subject(s)
Humans , Male , Female , Aged , Descemet Stripping Endothelial Keratoplasty/adverse effects , Choroid Hemorrhage/diagnostic imaging , Choroid Hemorrhage/etiology , Postoperative ComplicationsABSTRACT
This study, a case series of 2 patients and a literature review, aims to describe the second and third known cases of delayed suprachoroidal hemorrhage after Descemet stripping automated endothelial keratoplasty. The suprachoroidal hemorrhage is defined as the presence of blood in the suprachoroidal space; final visual acuity is rarely greater than 0.1 (decimal scale). Both cases presented had known risk factors: high myopia, previous ocular surgeries, arterial hypertension, and being under anticoagulant therapy. The diagnosis of delayed suprachoroidal hemorrhage was made at the 24-h follow-up visit, as they recalled a sudden and tremendous acute pain hours after surgery. Both cases were drained through a scleral approach. Delayed suprachoroidal hemorrhage is a rare but devastating consequence that can occur after Descemet stripping automated endothelial keratoplasty. Awareness of the most critical risk factors allows for early identification, which is of paramount importance for the prognosis of these patients.
